These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 81385)

  • 21. The effects of lecithin on memory in patients with senile dementia of the Alzheimer's type [proceedings].
    Vroulis GA; Smith RC; Brinkman S; Schoolar J; Gordon J
    Psychopharmacol Bull; 1981 Jan; 17(1):127-8. PubMed ID: 7232644
    [No Abstract]   [Full Text] [Related]  

  • 22. A dose-ranging study of lecithin in the treatment of primary degenerative dementia (Alzheimer disease).
    Brinkman SD; Pomara N; Goodnick PJ; Barnett N; Domino EF
    J Clin Psychopharmacol; 1982 Aug; 2(4):281-5. PubMed ID: 7119136
    [No Abstract]   [Full Text] [Related]  

  • 23. Early results from double-blind, placebo controlled trial of high dose phosphatidylcholine in Alzheimer's disease.
    Levy R; Little A; Chuaqui P; Reith M
    Lancet; 1983 Apr; 1(8331):987-8. PubMed ID: 6132292
    [No Abstract]   [Full Text] [Related]  

  • 24. Lecithin in Alzheimer's disease.
    Etienne P; Gauthier S; Dastoor D; Collier B; Ratner J
    Lancet; 1978 Dec; 2(8101):1206. PubMed ID: 82173
    [No Abstract]   [Full Text] [Related]  

  • 25. Lecithin in the treatment of Alzheimer's disease.
    Weintraub S; Mesulam MM; Auty R; Baratz R; Cholakos BN; Kapust L; Ransil B; Tellers JG; Albert MS; LoCastro S; Moss M
    Arch Neurol; 1983 Aug; 40(8):527-8. PubMed ID: 6347143
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroprotective effect of Alpinia galanga (L.) fractions on Aβ(25-35) induced amnesia in mice.
    Hanish Singh JC; Alagarsamy V; Diwan PV; Sathesh Kumar S; Nisha JC; Narsimha Reddy Y
    J Ethnopharmacol; 2011 Oct; 138(1):85-91. PubMed ID: 21911048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
    Acierno G
    Clin Ter; 1983 Apr; 105(2):135-45. PubMed ID: 6345054
    [No Abstract]   [Full Text] [Related]  

  • 28. Lecithin in Alzheimer's disease.
    Levy R
    Lancet; 1982 Sep; 2(8299):671-2. PubMed ID: 6125806
    [No Abstract]   [Full Text] [Related]  

  • 29. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease.
    Wettstein A
    Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risperidone in the treatment of elderly patients with psychosis of Alzheimer's disease and related dementias.
    Grossman F; Okamoto A; Turkoz I; Gharabawi G
    J Am Geriatr Soc; 2004 May; 52(5):852-3. PubMed ID: 15086685
    [No Abstract]   [Full Text] [Related]  

  • 31. Lithium-induced increases in red blood cell choline and memory performance in Alzheimer-type dementia.
    Brinkman SD; Pomara N; Barnett N; Block R; Domino EF; Gershon S
    Biol Psychiatry; 1984 Feb; 19(2):157-64. PubMed ID: 6424733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.
    Masterman D
    Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487
    [No Abstract]   [Full Text] [Related]  

  • 33. Early stages of late onset Alzheimer's disease. Diagnostic criteria, protein metabolism, precursor loading effects, neurochemical and neuropsychological applications.
    Forssell LG; Hellström A; Ericsson K; Winblad B
    Acta Neurol Scand Suppl; 1989; 121():1-95. PubMed ID: 2565644
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug treatment of memory defects in the elderly.
    Hollister LE
    Psychosomatics; 1984 Dec; 25(12 Suppl):23-8. PubMed ID: 6514989
    [No Abstract]   [Full Text] [Related]  

  • 35. Serotonin transporter and memory.
    Meneses A; Perez-Garcia G; Ponce-Lopez T; Tellez R; Castillo C
    Neuropharmacology; 2011 Sep; 61(3):355-63. PubMed ID: 21276807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
    Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasopressin-like peptides and the treatment of memory disorders in man.
    Jolles J
    Prog Brain Res; 1983; 60():169-82. PubMed ID: 6364210
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of desmopressin on normal and impaired memory.
    Jenkins JS; Mather HM; Coughlan AK
    J Neurol Neurosurg Psychiatry; 1982 Sep; 45(9):830-1. PubMed ID: 7131017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. length of clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Levy R
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():33. PubMed ID: 9305513
    [No Abstract]   [Full Text] [Related]  

  • 40. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.
    van Straaten EC; Harvey D; Scheltens P; Barkhof F; Petersen RC; Thal LJ; Jack CR; DeCarli C;
    J Neurol; 2008 Sep; 255(9):1302-8. PubMed ID: 18825439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.